← Leaderboards
Xianmei Meng
Elf Zone, Inc.
$349,999
Attributed
$349,999
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2017–18$500K$375K$250K$125K$0
'17
'18
Funding mix
By agency
NIH$349,999 · 1
By mechanism
R43$349,999 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Xenograft Model”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$15,940,517
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$6,727,999
- Paul Northcott · St. Jude Children'S Research Hospital$6,159,036
Research focus
Xenograft ModelIn VivoRecombinantsCytokineSouth AmericaLeukemiaHispanicsOverexpressionStandard Of CareXenograft ProcedureUnited StatesCentral AmericaB-Cell Acute LeukemiaCellsCytokine ReceptorsHigh RiskChildChemotherapyCellular TransductionAdvisory CommitteesAdolescentCostCommercializationCell Type